SCHEMBL16410814

SCHEMBL16410814

[N-]=[N+]=NCS(=O)(=O)c1ccccc1CN=NC1=Nc2ccccc2N(N)C12CCSCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410757 0.73 — —
SCHEMBL16410797 0.72 — —
SCHEMBL16410849 0.70 — —
SCHEMBL16410743 0.64 — —
SCHEMBL16410813 0.62 AMPD2 (0.33) —
SCHEMBL16410684 0.57 — —
SCHEMBL16410741 0.54 PDE7A (0.33) —
SCHEMBL16410869 0.53 GAA (0.33) —
SCHEMBL28575163 0.53 KAT2B (0.40) —
SCHEMBL16473570 0.53 KAT2B (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback